John P. Moore

55.7k total citations · 13 hit papers
384 papers, 37.5k citations indexed

About

John P. Moore is a scholar working on Virology, Immunology and Infectious Diseases. According to data from OpenAlex, John P. Moore has authored 384 papers receiving a total of 37.5k indexed citations (citations by other indexed papers that have themselves been cited), including 314 papers in Virology, 153 papers in Immunology and 149 papers in Infectious Diseases. Recurrent topics in John P. Moore's work include HIV Research and Treatment (314 papers), Immune Cell Function and Interaction (121 papers) and HIV/AIDS drug development and treatment (116 papers). John P. Moore is often cited by papers focused on HIV Research and Treatment (314 papers), Immune Cell Function and Interaction (121 papers) and HIV/AIDS drug development and treatment (116 papers). John P. Moore collaborates with scholars based in United States, Netherlands and United Kingdom. John P. Moore's co-authors include Quentin J. Sattentau, Per Johan Klasse, Dennis R. Burton, Rogier W. Sanders, Joseph Sodroski, Alexandra Trkola, David D. Ho, James Μ. Binley, Ian A. Wilson and Tatjana Dragic and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

John P. Moore

379 papers receiving 36.7k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficient Neutralization of Primary Isolates of HIV-1 by a Recombinant Human Monoclonal Antibody

1994 938 citations Dennis R. Burton, John P. Moore et al. Science profile →
Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1

1996 925 citations John P. Moore et al. Journal of Virology profile →
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5

1996 922 citations James Μ. Binley, William C. Olson et al. profile →
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer

2013 640 citations Jean‐Philippe Julien, Albert Cupo et al. Science profile →
AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

1998 634 citations John P. Moore et al. profile →
Broadly Neutralizing Antibodies Targeted to the Membrane-Proximal External Region of Human Immunodeficiency Virus Type 1 Glycoprotein gp41

2001 632 citations James Μ. Binley, John P. Moore et al. Journal of Virology profile →
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies

2013 629 citations Rogier W. Sanders, Albert Cupo et al. PLoS Pathogens profile →
HIV vaccine design and the neutralizing antibody problem

2004 610 citations Dennis R. Burton, John P. Moore et al. profile →
Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding

1993 543 citations John P. Moore et al. Journal of Virology profile →
Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding.

1991 531 citations Quentin J. Sattentau, John P. Moore profile →
Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In Vitro

2001 530 citations John P. Moore, Dennis R. Burton et al. Journal of Virology profile →
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer

2013 527 citations Dmitry Lyumkis, Jean‐Philippe Julien et al. Science profile →
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4

1990 517 citations John P. Moore, Quentin J. Sattentau et al. Science profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
John P. Moore	30.2k	16.8k	14.1k	10.0k	7.9k	384	37.5k
Joseph Sodroski	42.6k 1.4×	27.5k 1.6×	19.0k 1.3×	15.8k 1.6×	8.4k 1.1×	446	56.3k
Beatrice H. Hahn	29.9k 1.0×	15.2k 0.9×	18.1k 1.3×	9.0k 0.9×	2.7k 0.3×	416	44.7k
Peter D. Kwong	17.0k 0.6×	10.0k 0.6×	9.3k 0.7×	9.5k 1.0×	6.5k 0.8×	265	27.1k
David D. Ho	38.3k 1.3×	19.2k 1.1×	27.4k 1.9×	7.7k 0.8×	3.1k 0.4×	350	54.2k
David C. Montefiori	25.7k 0.9×	17.2k 1.0×	11.1k 0.8×	8.1k 0.8×	3.6k 0.5×	616	33.7k
John R. Mascola	19.4k 0.6×	13.2k 0.8×	10.0k 0.7×	7.0k 0.7×	5.2k 0.7×	346	27.6k
Barton F. Haynes	14.9k 0.5×	16.7k 1.0×	8.5k 0.6×	8.5k 0.8×	4.7k 0.6×	432	34.7k
Dennis R. Burton	26.5k 0.9×	19.8k 1.2×	12.9k 0.9×	21.9k 2.2×	18.4k 2.3×	481	54.4k
George M. Shaw	25.1k 0.8×	11.9k 0.7×	14.2k 1.0×	5.4k 0.5×	2.1k 0.3×	236	32.1k
Robert W. Doms	15.0k 0.5×	11.7k 0.7×	8.1k 0.6×	8.1k 0.8×	2.2k 0.3×	237	28.7k

Countries citing papers authored by John P. Moore

Since Specialization

Citations

This map shows the geographic impact of John P. Moore's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John P. Moore with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John P. Moore more than expected).

Fields of papers citing papers by John P. Moore

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John P. Moore. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John P. Moore. The network helps show where John P. Moore may publish in the future.

Co-authorship network of co-authors of John P. Moore

This figure shows the co-authorship network connecting the top 25 collaborators of John P. Moore. A scholar is included among the top collaborators of John P. Moore based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John P. Moore. John P. Moore is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Moore, John P.. (2025). The RV144 Trial Might Still Yield Useful Information. Current HIV Research. 23(6). 357–362.

Ringe, Rajesh P., Philippe Colin, Gabriel Ozorowski, et al.. (2023). Glycan heterogeneity as a cause of the persistent fraction in HIV-1 neutralization. PLoS Pathogens. 19(10). e1011601–e1011601. 5 indexed citations

Klasse, Per Johan & John P. Moore. (2022). Reappraising the Value of HIV-1 Vaccine Correlates of Protection Analyses. Journal of Virology. 96(8). e0003422–e0003422. 12 indexed citations

Moore, John P., et al.. (2021). T cell response in immunosuppressed redo-liver transplant recipients after COVID-19 infection and after first dose of vaccine against SARS-CoV-2. White Rose Research Online (University of Leeds, The University of Sheffield, University of York). 1 indexed citations

Klasse, Per Johan, Douglas F. Nixon, & John P. Moore. (2021). Immunogenicity of clinically relevant SARS-CoV-2 vaccines in nonhuman primates and humans. Science Advances. 7(12). 1 indexed citations

Schooten, Jelle van, Marlies M. van Haaren, Hui Li, et al.. (2021). Antibody responses induced by SHIV infection are more focused than those induced by soluble native HIV-1 envelope trimers in non-human primates. PLoS Pathogens. 17(8). e1009736–e1009736. 12 indexed citations

Dingens, Adam S., Keara D. Malone, Sarah K. Hilton, et al.. (2021). High-resolution mapping of the neutralizing and binding specificities of polyclonal sera post-HIV Env trimer vaccination. eLife. 10. 14 indexed citations

Moore, John P. & Per Johan Klasse. (2020). COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds. Journal of Virology. 94(17). 66 indexed citations

Moore, John P., et al.. (2020). Antibodies to SARS-CoV-2 and their potential for therapeutic passive immunization. eLife. 9. 52 indexed citations

10.

Cupo, Albert, et al.. (2019). Optimizing the production and affinity purification of HIV-1 envelope glycoprotein SOSIP trimers from transiently transfected CHO cells. PLoS ONE. 14(4). e0215106–e0215106. 15 indexed citations

11.

Rashad, Adel A., Francesca Moraca, Per Johan Klasse, et al.. (2017). Recognition of HIV-inactivating peptide triazoles by the recombinant soluble Env trimer, BG505 SOSIP.664. Proteins Structure Function and Bioinformatics. 85(5). 843–851. 5 indexed citations

12.

Julien, Jean‐Philippe, Albert Cupo, Devin Sok, et al.. (2013). Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer. Science. 342(6165). 1477–1483. 640 indexed citations breakdown →

13.

Lyumkis, Dmitry, Jean‐Philippe Julien, Natalia de Val, et al.. (2013). Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer. Science. 342(6165). 1484–1490. 527 indexed citations breakdown →

14.

Depetris, Rafael S., Jean‐Philippe Julien, Reza Khayat, et al.. (2012). Partial Enzymatic Deglycosylation Preserves the Structure of Cleaved Recombinant HIV-1 Envelope Glycoprotein Trimers. Journal of Biological Chemistry. 287(29). 24239–24254. 40 indexed citations

15.

Berro, Reem, Per Johan Klasse, Martin R. Jakobsen, et al.. (2012). V3 determinants of HIV-1 escape from the CCR5 inhibitors Maraviroc and Vicriviroc (vol 427, pg 158, 2012). Virology. 428(1). 3 indexed citations

16.

Melchers, Mark, Ilja Bontjer, Tommy Tong, et al.. (2011). Targeting HIV-1 Envelope Glycoprotein Trimers to B Cells by Using APRIL Improves Antibody Responses. Journal of Virology. 86(5). 2488–2500. 39 indexed citations

17.

Anastassopoulou, Cleo, Thomas J. Ketas, Per Johan Klasse, & John P. Moore. (2009). Resistance to CCR5 inhibitors caused by sequence changes in the fusion peptide of HIV-1 gp41. Proceedings of the National Academy of Sciences. 106(13). 5318–5323. 84 indexed citations

18.

Ingallinella, Paolo, Elisabetta Bianchi, Yingjie Wang, et al.. (2009). Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency. Proceedings of the National Academy of Sciences. 106(14). 5801–5806. 184 indexed citations

19.

Lopalco, Lucia, Renato Longhi, Anita De Rossi, et al.. (1993). Identification of Human Immunodeficiency Virus Type 1 Glycoprotein gp120/gp41 Interacting Sites by the Idiotypic Mimicry of Two Monoclonal Antibodies. AIDS Research and Human Retroviruses. 9(1). 33–39. 23 indexed citations

20.

Moore, John P., Quentin J. Sattentau, & Paul R. Clapham. (1990). Enhancement of Soluble CD4-Mediated HIV Neutralization and gp120 Binding by CD4 Autoantibodies and Monoclonal Antibodies. AIDS Research and Human Retroviruses. 6(11). 1273–1279. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact